Category Archives: SSRI Antidepressants

Featured Stories

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Exposure to Common Pesticide May Increase ADHD Risk

Exposure to Common Pesticide May Increase ADHD Risk

A new study has found that exposure to a common household pesticide may increase the risk of attention deficit hyperactivity disorder (ADHD) in children.

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Bleeding Side Effects of Pradaxa, Xarelto Have Some Doctors Concerned

Some heart doctors are raising concerns about a new class of heart drugs that include Pradaxa. Recently, a number of doctors interviewed by Reuters said they were hesitant to prescribe Pradaxa, as well as another blood thinner called Xarelto, because of concerns regarding the risk of stroke, serious bleeding ...

Read More

Government Penalizes 721 Hospitals for High Rates of Infections, Injuries

Medicare is reducing payments to 721 hospitals, one out of every seven hospitals in the nation, for having high rates of “hospital-acquired” conditions (HAC.

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.

Read More

SSRI Antidepressants Can Increase Patient’s Fear and Anxiety

SSRI Antidepressants Can Increase Patient’s Fear and Anxiety

For some of the millions of people worldwide who take selective serotonin re-uptake inhibitors (SSRIs) to treat depression, the drug may actually increase the patient’s fear and anxiety. This family of widely prescribed drugs includes Prozac (fluoxetine) and Zoloft (sertraline). … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants | Tagged , , , , , , , , , , , , , |

Forest Laboratories Denies Claims in Antidepressant Drug Multidistrict Litigation

  Forest Laboratories is facing claims in a multidistrict litigation (MDL) that alleges it misrepresented the efficacy of the antidepressant drugs Lexapro and Celexa for the treatment of depression in pediatric patients. Forest countered telling the Massachusetts federal court that … Continue reading

Posted in Consumer Fraud, Health Concerns, Pharmaceuticals, SSRI Antidepressants |

New Study Warns of Increased Bleeding Risk In Patients with Combined Use of Antidepressants and NSAIDs

Combining Antidepressants & NSAIDs Cause Bleeding Risks

Results of a new study from a research team in Korea indicate that the combined use of antidepressants and nonsteroidal anti-inflammatory drugs (NSAIDs), a common form of painkiller, is associated with an increased risk of intracranial bleeding. The authors write … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants | Tagged , , , , |

Following Husband’s Death, Widow’s Sues Over Allegedly Weak Warning Label on Generic Medication

A widow is suing the maker of  (paroxetine) tablets that her husband, 42 at the time of his death, took as prescribed in 2010. The widow alleges that just six paroxetine tablets led to her husband’s suicide and did not … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

SSRI Antidepressant Use in Pregnancy Tied to Autism Risk

A new study reports that boys with autism were three times more likely to have been exposed to SSRI antidepressants (selective serotonin reuptake inhibitors)  in the womb than typically developing children. Boys whose mothers took SSRIs – including Celexa (citalopram), … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants |

Maternal Use of SSRI Antidepressants Linked to Pulmonary Hypertension in Newborns

ssri-antidepressants-newborn-hypertension

New research shows that maternal use of SSRI antidepressants late in pregnancy is linked to increased risk for persistent pulmonary hypertension (PPH) in newborns. A meta-analysis of seven studies shows a significant association between PPH – increased pressure in the pulmonary arteries – in infants whose … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants |

Adipotrim XT Dietary Supplement Recalled for Undeclared Drug Ingredient

adipotrim-xt-supplement-recall

Deseo Rebajar Inc., is voluntarily recalling Adipotrim XT, a dietary supplement sold directly to customers in Fajardo, Caguas and Bayamon, Puerto Rico, and online. A U.S. Food and Drug Administration (FDA) laboratory analysis found it to contain undeclared fluoxetine, a selective … Continue reading

Posted in Health Concerns, Pharmaceuticals, Product Recalls, SSRI Antidepressants |

Study: SSRIs Use Tied to Upper GI Bleeds

ssri_tied_to_gi_tract_bleeding

The use of selective serotonin reuptake inhibitors (SSRIs) for as little as seven days presents significant increased risks for upper gastrointestinal (GI) bleeding events, according to a new study. “Consistent with previous studies, SSRIs were the only antidepressants found to … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

Study: Certain Antidepressants Linked to Increased Clostridium Difficile Risks

antidepressants-Clostridium-difficile-infections

The antidepressants mirtazapine—sold under the brands Remeron, Avanza, and Zispin—and fluoxetine (known as Prozac, Sarafem, or Fontex) have been associated with an increased risk Clostridium difficile infection (CDI), according to new research. Investigators at the University of Michigan in Ann … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

JAMA Study: Perioperative SSRI Use Associated with Increased Adverse Event Risks

SSRI-Adverse_Effects

A new study found that patients taking selective serotonin reuptake inhibitors (SSRIs) during the perioperative period (from hospitalization admission to discharge) were at increased risks for suffering an adverse event. The study appears in the April 29, 2013 issue of … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

© 2005-2020 Parker Waichman LLP ®. All Rights Reserved.